CYTOCANVAS
DEAD

Serial Number

98811827

Owner

Element Biosciences, Inc.

Attorney

Eryn Y. Truong

Filing Date

Oct 21, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CYTOCANVAS Trademark

Serial Number: 98811827

CYTOCANVAS is a trademark filed by Element Biosciences, Inc. on October 21, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Element Biosciences, Inc. (38 trademarks)

9880 Campus Point Drive, Suite 210
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

October 21, 2024

Registration Date

Not Registered

Goods & Services

Clinical diagnostic instruments for medical use, namely, nucleic acid sequencers, imaging devices and analyzers

Providing reagent sample diagnostic testing services for others for scientific research purposes and scientific research related thereto; clinical diagnostic services for scientific research purposes, namely, preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids from human beings

Computer systems, namely, computer hardware, downloadable and recorded computer software and associated downloadable data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable and recorded computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; clinical diagnostic instruments for scientific use, namely, nucleic acid sequencers, imaging devices and analyzers

Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for scientific research use, for diagnostic scientific use, and for clinical laboratory research use; clinical diagnostic reagents for laboratory use; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic laboratory purposes

Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical medical diagnostic purposes; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for diagnostic medical use and for clinical medical use

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 12, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 12, 2025 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 18, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 18, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 29, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 29, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 29, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 22, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 21, 2025 NWOS
NEW APPLICATION ENTERED
Oct 21, 2024 NWAP